UNSPSC 51131618: Beraprost

This classification denotes a prostaglandin analogue with the molecular formula C24H30O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 35E3NJJ4O6, chemically known as 2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2,3,3a,8b-tetrahydro-1h-cyclopenta(b)benzofuran-5-butanoic acid but generally known as beraprost, which bears US NIH Compound Identifier 5282428. Beraprost most often comes in base and sodium forms.

UNSPSC 51131618 Beraprost (Commodity) shows minimal recent state and local procurement activity aligned with its pharmaceutical scope. The single recent opportunity on record—Sourcewell RFP #061626, posted May 12, 2026 with a response date of June 16, 2026—is soliciting law enforcement equipment for participating counties and public entities across multiple states, a category plainly unrelated to beraprost, a pharmaceutical vasoprotective agent. The code's abstract name does not match what is actually being bought in this instance, and no other recent opportunities under this Commodity code appear in the current dataset.

State and local purchasing under this code shows no coherent pattern of activity across issuing bodies or geographic regions based on available records. The mismatch between the Commodity's pharmaceutical scope and the law enforcement-equipment categorization in the sole recent solicitation suggests either a tagging error in the state and local procurement system or minimal legitimate demand for this specific pharmaceutical under formal state and local contracting vehicles. Firms evaluating this code should verify current demand through direct outreach to state Medicaid programs, public health agencies, and hospital cooperative purchasing groups before committing resources to pursue opportunities tagged under this Commodity.